Prescriber's Letter

July 2020 Issue

A deluge of COVID-19 social media posts will have patients asking you how to identify trustworthy information and resources...

You’ll get more questions about diagnostic and antibody tests for SARS-CoV-2...as testing for COVID-19 continues to ramp up...

There’s not a hard-and-fast rule to know whether to start or stop meds for Alzheimer’s disease...

You’ll get questions about managing chronic gout...due to continued debate over whether to aim for a target uric acid level...

Healthcare worker wearing PPE performs a nasal swab

Trijardy XR
empagliflozin/linagliptin/metformin
New combination formulation for glycemic control in patients with type 2 diabetes

Nexletol
bempedoic acid
An adenosine triphosphate-citrate lyase inhibitor for hypercholesterolemia

Anjeso
meloxicam
New injectable meloxicam for acute pain